Wugen
wugen.comLocations
St. Louis, MO, USA · Missouri City, MO, USA
industry
Biotechnology
Size
51-200 employees
Stage
Series B
founded in
2018
Wugen is a clinical-stage biotechnology company developing the next generation of off-the-shelf memory natural killer (NK) and CAR-T cell therapies for cancer. Wugen is leveraging its proprietary Moneta platform and deep genomic engineering expertise to pioneer a new class of memory NK cell therapies to treat hematological and solid tumor malignancies. Wugen is based out of St. Louis, Missouri, and San Diego, California.
Something looks off?Open jobs at Wugen
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.